Kaso ng COVID-19 sa Central Visayas mahigit 16,500 na

By Dona Dominguez-Cargullo August 03, 2020 - 08:24 AM

Sumampa na sa mahigit 16,500 ang kaso ng COVID-19 sa Central Visayas.

Ito ay makaraang makapagtala pa ng dagdag na 92 na bagong kaso ng sakit kahapon.

Ayon sa DOH-Central Visayas Center for Health Development, 16,586 na ang total confirmed cases ng COVID-19 sa rehiyon.

Sa nasabing bilang, 6,075 na lang ang aktibong kaso.

Umabot naman na sa 854 ang bilang ng nasawi dahil sa COVID-19 sa Central Visayas.

Habang nakapagtala ng dagdag na bilang ng recoveries na umabot sa 83 dahilan para umabot na sa 9,657 ang bilang ng mga gumaling sa sakit.

Malaking bilang ng kaso ng COVID-19 sa Central Visayas ay sa Cebu City na nakapagtala na ng 9,075 cases.

Narito naman ang kaso ng COVID-19 sa iba pang mga lalawigan at lungsod sa rehiyon:

Cebu Province – 1,856
– Talisay City – 778
– Minglanilla – 408
– Consolacion – 408
Mandaue City – 1,985
Lapu-Lapu City – 1,876
Negros Oriental – 109
Bohol – 90
Siquijor – 1

 

 

TAGS: Central Visayas, covid pandemic, COVID-19, COVID-19 cases, department of health, general community quarantine, Health, Inquirer News, Modified general community quarantine, News in the Philippines, Radyo Inquirer, State of Emergency, Tagalog breaking news, tagalog news website, Central Visayas, covid pandemic, COVID-19, COVID-19 cases, department of health, general community quarantine, Health, Inquirer News, Modified general community quarantine, News in the Philippines, Radyo Inquirer, State of Emergency, Tagalog breaking news, tagalog news website

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.